Krebs Biochemicals and Industries Ltd posts Rs. 8.13 crores loss in Q1 FY23

Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 10.7699 crores during the period ended June 30, 2022 as compared to Rs. 19.9503 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. -8.1367 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -11.3139 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. -3.77 for the period ended June 30, 2022 as compared to Rs. -5.39 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 10.7699 crs	₹19.9503 crs	-46.02%
Net Profit	₹-8.1367 crs	₹-11.3139 crs	28.08%
EPS	₹-3.77	₹-5.39	30.06%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 10.7699 crores during the period ended June 30, 2022 as compared to Rs.6.7852 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.-8.1367 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-9.4235 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.-3.77 for the period ended June 30, 2022 as compared to Rs.-4.37 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 10.7699 crs	₹6.7852 crs	58.73%
Net Profit	₹-8.1367 crs	₹-9.4235 crs	13.66%
EPS	₹-3.77	₹-4.37	13.73%

Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 118.90 as compared to the previous close of Rs. 119.30. The total number of shares traded during the day was 1579 in over 56 trades.

The stock hit an intraday high of Rs. 121.45 and intraday low of 117.90. The net turnover during the day was Rs. 188161.00.

Source : Equity Bulls

Keywords

KrebsBiochemicalsandIndustries Q1FY23 ResultUpdate